Education
About Us
Working with TipRanks
Follow Us
Opus Genetics (IRD)
NASDAQ:IRD
Total Valuation
Opus Genetics has a market cap or net worth of $59.16M. The enterprise value is -$22.65M.
Market Cap$59.16M
Enterprise Value-$22.65M
Share Statistics
Opus Genetics has 59,661,198 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding59,661,198
Owned by Insiders23.82%
Owned by Institutions20.71%
Financial Efficiency
Opus Genetics’s return on equity (ROE) is -8.56 and return on invested capital (ROIC) is -242.79%.
Return on Equity (ROE)-8.56
Return on Assets (ROA)-1.56
Return on Invested Capital (ROIC)-242.79%
Return on Capital Employed (ROCE)-2.43
Revenue Per Employee610.67K
Profits Per Employee-3.20M
Employee Count18
Asset Turnover0.30
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Opus Genetics is -0.55. Opus Genetics’s PEG ratio is 0.02.
PE Ratio-0.55
PS Ratio0.00
PB Ratio0.56
Price to Fair Value4.73
Price to FCF-25.05
Price to Operating Cash Flow-25.05
PEG Ratio0.02
Income Statement
In the last 12 months, Opus Genetics had revenue of 10.99M and earned -57.53M in profits. Earnings per share was -2.15.
Revenue10.99M
Gross Profit10.98M
Operating Income-62.07M
Pretax Income-57.53M
Net Income-57.53M
EBITDA-57.52M
Earnings Per Share (EPS)-2.15
Cash Flow
In the last 12 months, operating cash flow was -25.58M and capital expenditures 0.00, giving a free cash flow of -25.58M billion.
Operating Cash Flow-25.58M
Free Cash Flow-25.58M
Free Cash Flow per Share-0.43
Dividends & Yields
Opus Genetics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.66
52-Week Price Change-42.26%
50-Day Moving Average0.92
200-Day Moving Average1.10
Relative Strength Index (RSI)47.26
Average Volume (3m)1.62M
Important Dates
Opus Genetics upcoming earnings date is Aug 8, 2025, TBA Not Confirmed.
Last Earnings DateMay 15, 2025
Next Earnings DateAug 8, 2025
Ex-Dividend Date―
Financial Position
Opus Genetics as a current ratio of 3.24, with Debt / Equity ratio of 0.00%
Current Ratio3.24
Quick Ratio3.24
Debt to Market Cap0.00
Net Debt to EBITDA0.53
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Opus Genetics has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Opus Genetics EV to EBITDA ratio is -0.03, with an EV/FCF ratio of -0.06.
EV to Sales0.13
EV to EBITDA-0.03
EV to Free Cash Flow-0.06
EV to Operating Cash Flow-0.06
Balance Sheet
Opus Genetics has $30.32M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$30.32M billion.
Cash & Marketable Securities$30.32M
Total Debt$0.00
Net Cash-$30.32M
Net Cash Per Share-$0.51
Tangible Book Value Per Share$0.25
Margins
Gross margin is 100.00%, with operating margin of -564.72%, and net profit margin of -523.40%.
Gross Margin100.00%
Operating Margin-564.72%
Pretax Margin-523.40%
Net Profit Margin-523.40%
EBITDA Margin-523.31%
EBIT Margin-523.40%
Analyst Forecast
The average price target for Opus Genetics is $6.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$6.33
Price Target Upside552.58% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast-42.30%
EPS Growth Forecast-330.51%